Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1980 1
1982 1
1987 2
1988 1
1992 1
1993 2
2001 2
2002 1
2003 2
2004 2
2005 1
2007 1
2009 1
2013 2
2014 2
2016 1
2018 1
2019 1
2020 2
2021 2
2022 1
2023 1
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

32 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Refractory Rectal Adenocarcinoma"
Page 1
Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study.
Dasari A, Lonardi S, Garcia-Carbonero R, Elez E, Yoshino T, Sobrero A, Yao J, García-Alfonso P, Kocsis J, Cubillo Gracian A, Sartore-Bianchi A, Satoh T, Randrian V, Tomasek J, Chong G, Paulson AS, Masuishi T, Jones J, Csőszi T, Cremolini C, Ghiringhelli F, Shergill A, Hochster HS, Krauss J, Bassam A, Ducreux M, Elme A, Faugeras L, Kasper S, Van Cutsem E, Arnold D, Nanda S, Yang Z, Schelman WR, Kania M, Tabernero J, Eng C; FRESCO-2 Study Investigators. Dasari A, et al. Lancet. 2023 Jul 1;402(10395):41-53. doi: 10.1016/S0140-6736(23)00772-9. Epub 2023 Jun 15. Lancet. 2023. PMID: 37331369 Clinical Trial.
INTERPRETATION: Fruquintinib treatment resulted in a significant and clinically meaningful benefit in overall survival compared with placebo in patients with refractory metastatic colorectal cancer. These data support the use of fruquintinib as a global treatment option fo …
INTERPRETATION: Fruquintinib treatment resulted in a significant and clinically meaningful benefit in overall survival compared with placebo …
Treatment-resistant severe capecitabine-induced diarrhoea resolved with oral budesonide.
Shumar J, Junga Z, Johnson JT, Goldkind L. Shumar J, et al. BMJ Case Rep. 2019 Dec 1;12(11):e231544. doi: 10.1136/bcr-2019-231544. BMJ Case Rep. 2019. PMID: 31791985 Free PMC article.
We describe a case of a patient with severe capecitabine-induced diarrhoea that was refractory to guideline based therapy but resolved with the use of budesonide....
We describe a case of a patient with severe capecitabine-induced diarrhoea that was refractory to guideline based therapy but resolve …
Modified simultaneous integrated boost radiotherapy for an unresectable huge refractory pelvic tumor diagnosed as a rectal adenocarcinoma.
Nomiya T, Akamatsu H, Harada M, Ota I, Hagiwara Y, Ichikawa M, Miwa M, Kawashiro S, Hagiwara M, Chin M, Hashizume E, Nemoto K. Nomiya T, et al. World J Gastroenterol. 2014 Dec 28;20(48):18480-6. doi: 10.3748/wjg.v20.i48.18480. World J Gastroenterol. 2014. PMID: 25561820 Free PMC article.
A clinical trial of radiotherapy with modified simultaneous integrated boost (SIB) technique against huge tumors was conducted. A 58-year-old male patient who had a huge pelvic tumor diagnosed as a rectal adenocarcinoma due to familial adenomatous poly …
A clinical trial of radiotherapy with modified simultaneous integrated boost (SIB) technique against huge tumors was conducted …
Meningorectal fistula as a cause of polymicrobial anaerobic meningitis.
Walsh TJ, Weinstein RA, Malinoff H, Breyer MD, Berelowitz BA. Walsh TJ, et al. Am J Clin Pathol. 1982 Jul;78(1):127-30. doi: 10.1093/ajcp/78.1.127. Am J Clin Pathol. 1982. PMID: 7102600
A 49-year-old diabetic woman developed polymicrobial anaerobic meningitis secondary to a meningorectal fistula one year after receiving neutron beam therapy for a rectal adenocarcinoma. The meningitis was refractory to chloramphenicol and penicillin but respo …
A 49-year-old diabetic woman developed polymicrobial anaerobic meningitis secondary to a meningorectal fistula one year after receiving neut …
Abnormal Neuronal Response to Rectal and Anal Stimuli in Patients Treated for Distal Rectal Cancer With High-Dose Chemoradiotherapy Followed By Watchful Waiting.
Haas S, Møller Faaborg P, Brock C, Krogh K, Gram M, Lundby L, Mohr Drewes A, Laurberg S, Christensen P. Haas S, et al. Dis Colon Rectum. 2020 Sep;63(9):1234-1241. doi: 10.1097/DCR.0000000000001610. Dis Colon Rectum. 2020. PMID: 33216494
BACKGROUND: Watchful waiting in patients with rectal cancer with complete clinical response after chemoradiation therapy has gained increased popularity to avoid morbidity and mortality associated with surgery. ...CONCLUSIONS: Chemoradiation therapy for distal re …
BACKGROUND: Watchful waiting in patients with rectal cancer with complete clinical response after chemoradiation therapy has g …
Surgery for ulcerative colitis complicated with colorectal cancer: when ileal pouch-anal anastomosis is the right choice.
Tonelli F, Di Martino C, Amorosi A, Mini E, Nesi G. Tonelli F, et al. Updates Surg. 2022 Apr;74(2):637-647. doi: 10.1007/s13304-022-01250-4. Epub 2022 Feb 25. Updates Surg. 2022. PMID: 35217982 Free PMC article.
IPAA was possible in 6/9 rectal CC. Cumulative survival rate 5 and 10 years after surgery was 61% and 53%, respectively. The survival rate was significantly lower for mucinous or signet-ring carcinomas than for other adenocarcinoma. No significant differences of the …
IPAA was possible in 6/9 rectal CC. Cumulative survival rate 5 and 10 years after surgery was 61% and 53%, respectively. The survival …
Rectourethral fistula and massive rectal bleeding from iodine-125 prostate brachytherapy: a case report.
Cherr GS, Hall C, Pineau BC, Waters GS. Cherr GS, et al. Am Surg. 2001 Feb;67(2):131-4. Am Surg. 2001. PMID: 11243535 Review.
Gastrointestinal complications of brachytherapy (minor rectal bleeding or tenesmus) are uncommon. Rectal ulceration or rectourethral fistulas after prostate brachytherapy are rare. We present a case of massive refractory rectal bleeding and rectourethr …
Gastrointestinal complications of brachytherapy (minor rectal bleeding or tenesmus) are uncommon. Rectal ulceration or rectour …
32 results